Ipilimumab and Dermatitis
Result of checking the interaction of drug Ipilimumab and disease Dermatitis for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Immune-mediated dermatitis, including fatal cases, have occurred with ipilimumab therapy. Monitor patients for signs and symptoms of dermatitis, such as rash and pruritus. Unless an alternate etiology has been identified, signs or symptoms of dermatitis should be considered immune-mediated. Permanently discontinue ipilimumab in patients with Stevens-Johnson syndrome, toxic epidermal necrolysis, or rash complicated by full thickness dermal ulceration, or necrotic, bullous, or hemorrhagic manifestations. Withhold ipilimumab dosing in patients with moderate to severe signs and symptoms.
Ipilimumab - zapalenie skóry 
Ipilimumab - dermatite 
Ipilimumab - dermatitis 
Ipilimumab - infeksi kulit 
Ipilimumab - dermatite 
Ipilimumab - dermatite 
Ipilimumab - Dermatitis 
Ipilimumab - dermatitis 
Ipilimumab - дерматит 
Ipilimumab - dermatit 
Ipilimumab - التهاب الجلد 
Ipilimumab - 皮炎